netFormulary
 Report : A-Z CDF items in Formulary 12/04/2021 01:11:35
[Back]
 
Section Status CDF Name
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios®
08.01.05 Formulary Cancer Drugs Fund Acalabrutinib Calquence®
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
08.01.05 Formulary Cancer Drugs Fund Avelumab Bavencio®
08.01.05 Restricted Use Cancer Drugs Fund Axicabtagene ciloleucel YESCARTA®
08.01.01 Formulary Cancer Drugs Fund Bendamustine Levact®
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Formulary Cancer Drugs Fund Binimetinib Mektovi®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01 Formulary Cancer Drugs Fund Cabozantinib Cometriq®
08.01.05 Formulary Cancer Drugs Fund Cemiplimab Libtayo®
08.01.03 Formulary Cancer Drugs Fund Clofarabine Evoltra®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Formulary Cancer Drugs Fund Daratumumab DARZALEX®
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Hydrochloride Caelyx®
08.01.05 Formulary Cancer Drugs Fund Durvalumab Imfinzi®
08.01.05 Formulary Cancer Drugs Fund Encorafenib Braftovi®
08.01.05 Formulary Cancer Drugs Fund Entrectinib Rozlytrek®
08.03.04.01 Formulary Cancer Drugs Fund Fulvestrant Faslodex®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
08.01.05 Formulary Cancer Drugs Fund Ipilimumab YERVOY ®
08.01.05 Formulary Cancer Drugs Fund Isatuximab Sarclisa®
08.01.05 Formulary Cancer Drugs Fund Ixazomib Ninlaro®
08.01.05 Restricted Use Cancer Drugs Fund Larotrectinib Vitrakvi®
08.02.04 Formulary Cancer Drugs Fund Lenalidomide Revlimid®
08.01.05 Formulary Cancer Drugs Fund Lutetium (177Lu) oxodotreotide Lutathera®
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance®
08.01.05 Formulary Cancer Drugs Fund Niraparib Zejula®
08.01.05 Formulary Cancer Drugs Fund Nivolumab Opdivo®
08.01.05 Formulary Cancer Drugs Fund Olaparib Lynparza®
08.01.05 Non Formulary Cancer Drugs Fund Olaratumab Lartruvo®
08.01.05 Formulary Cancer Drugs Fund Palbociclib IBRANCE®
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.05 Formulary Cancer Drugs Fund Pemigatinib Pemazyre®
08.01.05 Formulary Cancer Drugs Fund Ribociclib Kisqali®
08.01.05 Formulary Cancer Drugs Fund Rucaparib Rubraca®
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar®
08.01.05 Restricted Use Cancer Drugs Fund Tisagenlecleucel Kymriah®
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
Dorset